SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
16-Jan-24 8:14 PM View: | Desilva Tara Director | Coeptis Therapeutics Holdin... (COEP) | 12-Jan-24 | Private Purchase | 2,266 | $0.58 | $1,304.96 | 8% 30.0K to 32.27K | |
17-Jan-24 4:03 PM View: | Cogley Brian Chief Financial Officer | Coeptis Therapeutics Holdin... (COEP) | 10-Jan-24 | Private Purchase | 5,000 | $0.67 | $3,350.00 | 20% 25.0K to 30.0K | |
09-Jan-24 5:30 PM View: | Mehalick David CEO and President Director 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 08-Jan-24 | Purchase | 20,004 | $0.66 | $13,262.60 | < 1% 2.76M to 2.78M | |
09-Jan-24 5:30 PM View: | Cochran Christopher P. Director | Coeptis Therapeutics Holdin... (COEP) | 05-Jan-24 | Private Purchase | 7,000 | $0.77 | $5,390.00 | 23% 30.0K to 37.0K | |
09-Jan-24 5:32 PM View: | Yerace Daniel Alexander VP of Operations Director | Coeptis Therapeutics Holdin... (COEP) | 05-Jan-24 | Private Purchase | 10,850 | $0.69 | $7,486.50 | 1% 1.06M to 1.07M | |
09-Jan-24 5:30 PM View: | Mehalick David CEO and President Director 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 05-Jan-24 | Private Purchase | 5,050 | $0.69 | $3,484.50 | < 1% 2.76M to 2.76M | |
09-Jan-24 5:31 PM View: | Salkind Gene Director | Coeptis Therapeutics Holdin... (COEP) | 05-Jan-24 | Private Purchase | 11,600 | $0.69 | $8,004.00 | 4% 305.14K to 316.74K | |
11-Dec-23 4:01 PM View: | Mehalick David CEO and President Director 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 07-Dec-23 | Gift | 700,000 | -- | -- | (20%) 3.46M to 2.76M | |
30-Aug-23 3:15 PM View: | Salkind Gene Director | Coeptis Therapeutics Holdin... (COEP) | 29-Aug-23 | Purchase | 4,006 | $1.01 | $4,046.06 | 1% 278.72K to 282.73K | |
30-Aug-23 3:15 PM View: | Salkind Gene Director | Coeptis Therapeutics Holdin... (COEP) | 25-Aug-23 | Private Purchase | 28,638 | $0.91 | $26,060.60 | 11% 250.09K to 278.72K | |
31-Aug-23 4:01 PM View: | Calise Chris Director | Coeptis Therapeutics Holdin... (COEP) | 23-Aug-23 | Private Purchase | 11,582 | $0.94 | $10,878.60 | < 1% 1.45M to 1.46M | |
06-May-22 6:19 PM View: | Harraden Circle Investments... 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 04-May-22 | Market Sale | 85,305 | $10.11 | $862,434.00 | (17%) 514.44K to 429.13K | (< 1%) |
26-May-21 5:41 PM View: | Glazer Capital, LLC 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 26-May-21 | Market Sale | 6,118 | $9.85 | $60,262.30 | (< 1%) 970.54K to 964.42K | (13%) |
26-May-21 5:41 PM View: | Glazer Capital, LLC 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 25-May-21 | Market Sale | 50,000 | $9.85 | $492,500.00 | (5%) 1.07M to 1.02M | (12%) |
14-Dec-20 5:10 PM View: | Striar Robert Chief Executive Officer Director 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 14-Dec-20 | Disposition (other) Duplicate | 281,250 | -- | -- | (13%) 2.16M to 1.88M | |
14-Dec-20 5:11 PM View: | Bull Horn Holdings Sponsor ... 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 14-Dec-20 | Disposition (other) | 281,250 | -- | -- | (13%) 2.16M to 1.88M | |
14-Dec-20 5:08 PM View: | Calise Chris Chief Financial Officer Director 10% Owner | Coeptis Therapeutics Holdin... (COEP) | 14-Dec-20 | Disposition (other) Duplicate | 281,250 | -- | -- | (13%) 2.16M to 1.88M |